Zenicor Medical Systems is active in medical technology. Today the focus is on diagnostics in heart care. The technology is based on the company's platform, which is used to identify and diagnose potential atrial fibrillation and other cardiac fibrillation disorders. The largest business is found in the European market. The company was established in 2003 and is based in Stockholm.

Quotes for Zenicor Medical Systems AB

Right Now

+/-
0.08
%
2,90%
Latest
2.84
High
2.84
Low
2.7
Volume
1 810
Turnover (SEK)
4 922
Market Value (MSEK)
25,6
Time (Latest trade)
2024-04-26 09:22

Board

CEO

  • Mats Palerius

Chairperson of the Board

  • Håkan Jansson

Board

  • Gundars Rasmanis
  • Lena Kajland Wilén
  • Mats Palerius
  • Sonny Norström

Largest Owners

Name Capital % Votes % Date
Sonny Norström 10,04 10,04 2024-03-26
Ragnar Winell 9,33 9,33 2024-03-26
Mats Palerius 9,27 9,27 2024-03-26
Avanza Pension 7,41 7,41 2024-03-26
Sören Mellstig 6,75 6,75 2024-03-26
Pei-Quan Ye 4,28 4,28 2024-03-26
Gundars Rasmanis 3,82 3,82 2024-03-26
Nordnet Pensionsförsäkring 3,37 3,37 2024-03-26
Staffan Eriksson 3,05 3,05 2024-03-26
Peyman Pournouri 1,83 1,83 2024-03-26
** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

Insider trading

Key Numbers

*Compiled data from Millistream

Upcoming reports

  • 2024-04-26 Delårsrapport 2024-Q1

  • 2024-05-28 Årsstämma 2023

  • 2024-08-02 Delårsrapport 2024-Q2

  • 2024-10-25 Delårsrapport 2024-Q3

  • 2025-02-14 Bokslutskommuniké 2024